SOAT1 and non-small cell lung carcinoma: More recent findings showed that GA (100 mg/kg) inhibited the growth of non-small cell lung cancer cells (NSCLC) in patient-derived xenograft (PDX) mice by suppressing the level of high mobility group box 1 (HMGB1) and inhibition of JAK/STAT signaling pathway (Wu et al., 2018b).